News

The program is focused on small molecules that prevent a receptor called CSF-1R or cFMS in the body that plays a major role in the immune response to

The injection is used in lymphatic mapping procedures that help in the diagnostic evaluation of potential cancer spread for patients with breast cancer and melanoma. The US Food

The two studies, Echo 1 and Echo 2, which will be conducted at close to 200 sites worldwide, will enroll nearly 1700 patients. The studies will assess the

As per the agreement, ChemRar Ventures will source early and late stage compounds within a certain defined area of Sanofi’s therapeutic interest and negotiating the potential pharma partnering

The collaboration aims to establish integrin peptide therapy as the first-in-class treatment that targets integrin with an oligopeptide to improve the quality of life for patients with risk

The collaboration will focus on the discovery, development and commercialisation of small-molecule therapies directed against three novel targets to treat metabolic diseases specially type 2 diabetes. Abide Therapeutics

The company anticipates that one kilogram of Adva-27a will be sufficient to complete the upcoming IND-Enabling animal toxicity studies and Phase I clinical trials. By completing the animal

Studies have shown that sustained cystine depletion in patients may significantly delay disease progression, including kidney dysfunction, dialysis, kidney transplant, organ failure and premature death. Raptor CEO and

The technology designed with air-wheel mixing system enables maximum operation efficiency and requires less space. PBS Bioreactors are scalable from 3lt to 2500lt. PBS Biotech president Brian Lee